The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Mccallum Stewart since year 2005.
The trader's CIK number is 1659872.
At the time of this reporting, Mccallum Stewart is the Chief Medical Officer of Recro Pharma, Inc. .
(stock ticker symbol REPH).
See this page for all insider trading activities at Recro Pharma, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-18||REPH||Recro Pharma, Inc.||Option Ex||6,000||.00||0|
|2017-09-28||REPH||Recro Pharma, Inc.||Option Ex||15,000||.00||0|
|2016-05-31||REPH||Recro Pharma, Inc.||Buy||250||8.50||2,125|
|2016-05-26||REPH||Recro Pharma, Inc.||Buy||1,000||8.15||8,150|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mccallum Stewart (Chief Medical Officer of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.